Key result
Shen-Fu formula significantly alleviated myocardial fibrosis and hypertrophy, improved cardiac function, and synergistically mediated the metabolic flexibility of fatty acids and glucose in TAC-induced heart failure mice.
Why the study?
Targeting cardiac metabolic remodeling has therapeutic potential in heart failure, and Shen-Fu formula is a promising combinatorial therapy whose therapeutic targets and cardioprotective mechanisms required investigation.
Does Shen-Fu formula improve cardiac function and attenuate metabolic remodeling in a mouse model of pressure overload-induced heart failure?
Does Shen-Fu formula improve cardiac function and attenuate metabolic remodeling in a mouse model of pressure overload-induced heart failure?
Answers are grounded in this paper and cite their sources.
Shen-Fu formula attenuates cardiac metabolic remodeling and improves heart function in a mouse model of pressure overload-induced heart failure by regulating fatty acid and glucose metabolism via AMPK activation.
Cardiac metabolic remodeling is recognized as an important hallmark of heart failure (HF), while strategies that target energy metabolism have therapeutic potential in treating HF. Shen-Fu formula (S-F) is a standardized herbal preparation frequently used in clinical practice and is a promising combinatorial therapy for HF-related metabolic remodeling. Herein, we performed an untargeted multi-omics analysis using transcriptomics, proteomics, and metabolomics on HF mice induced by transverse aortic constriction (TAC). Integrated and pathway-driven analyses were used to reveal the therapeutic targets associated with S-F treatment. The cardioprotective effect and potential mechanism of S-F were verified by the results from echocardiography, hemodynamics, histopathology, and biochemical assays. As a result, S-F significantly alleviated myocardial fibrosis and hypertrophy, thus reducing the loss of heart function during adverse cardiac remodeling in TAC mice. Integrated omics analysis showed that S-F synergistically mediated the metabolic flexibility of fatty acids and glucose in cardiac energy metabolism. These effects of S-F were confirmed by the activation of AMP-activated protein kinase (AMPK) and its downstream targets in the failing heart. Collectively, our results demonstrated that S-F suppressed cardiac metabolic remodeling through activating AMPK-related pathways via energy-dependent mechanisms.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2020) studied Heart failure (n=249). Shen-Fu formula (S-F) vs. TAC (model) and valsartan was evaluated on Cardiac function and metabolic remodeling. Shen-Fu formula significantly alleviated myocardial fibrosis and hypertrophy, improved cardiac function, and synergistically mediated the metabolic flexibility of fatty acids and glucose in TAC-induced heart failure mice.
Synapse has enriched 10 related papers. Consider them for comparative context: